AstraZeneca Latest News: AstraZeneca (AZN Limited), the manufacturer of ‘Covishield’, will withdraw its corona vaccine from across the world. On Tuesday (May 7, 2024), the British-Swedish origin multinational pharmaceutical and biotechnology company informed that it has started the process of withdrawing the vaccine. In the report of news agency ‘Reuters’, the company was further quoted as saying that it has to take this step due to decline in demand.
AZN Limited informed that it will proceed to withdraw the marketing authorization of Vaxzevria vaccine in Europe. According to the company’s statement, “Many Covid-19 vaccines have been made after the Corona epidemic. In such a situation, updated vaccines are also available in the markets.” AstraZeneca also said that there are already many vaccines in the market, so there has been a decline in demand for its Vaxjaveria vaccine. This is the reason why it is neither being manufactured nor supplied now.
There may be a risk of blood clot – company’s confession in court
This step has been taken by the company making the Covid-19 vaccine, a few days ago, AstraZeneca admitted for the first time in court documents that its vaccine, developed in partnership with the University of Oxford, could pose a risk of rare and serious blood clots. Is. However, amidst reports of the vaccine being faulty, health experts had said that the benefits of the vaccine are more and the disadvantages are very less. In such a situation, there is no need to worry about Covishield vaccine. The vaccine is safe and any side effects that may occur would have occurred only after vaccination.
AstraZeneca vaccine is known as Covishield in India
The Oxford-AstraZeneca Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, is a viral vector vaccine, which was developed using a modified chimpanzee adenovirus. Covishield, manufactured and marketed in Hindustan in partnership with the Serum Institute of India (SII), was widely administered in the country to nearly 90% of the Indian population.
